LDX 2.56% 4.0¢ lumos diagnostics holdings limited

The re-rate journey, page-258

  1. 943 Posts.
    lightbulb Created with Sketch. 188
    The good point I obtained from the article is that Lumos is undervalued compared with the industry just based on recent revenue, not projected revenue.

    Projected revenue is not a given, but looking at the journey so far we are headed in the right direction, given we now have 2 new FDA approved products to sell in the market which includes the company's current flagship FebriDx.

 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $19.25M
Open High Low Value Volume
4.0¢ 4.0¢ 3.8¢ $30.93K 791.3K

Buyers (Bids)

No. Vol. Price($)
1 100000 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 51842 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.